Literature DB >> 15131584

How do we avoid developing allergy: modifications of the TH2 response from a B-cell perspective.

Rob C Aalberse1, Thomas A E Platts-Mills.   

Abstract

The synthesis of IgE by B cells occurs at a low rate compared with that of other antibodies, even in allergic subjects. One rate-limiting step is the class switch, by which B lymphocytes switch to produce immunoglobulin epsilon heavy chains rather than micro or gamma heavy chains. We propose an additional rate-limiting step: survival of the B lymphocyte after the switch to IgE. The hypothesis we present here is that the survival of the IgE-switched B cell is compromised, particularly in an active germinal center. Antigenic stimulation in the absence of a danger signal fails to induce a mature germinal center, which allows IgE-switched B cells to escape and mature into plasma cells. Antigenic stimulation in the presence of a danger signal (or under nonhygienic conditions) induces germinal centers, which eliminate IgE-switched B cells. Thus the essence of an allergen is antigenic stimulation in the absence of conditions that generate mature germinal centers. Because germinal centers are important for the generation of B-cell memory, the IgE immune response is characteristically poor in memory (but might be long lasting because of the generation of long-lived plasma cells). In addition to this direct route to IgE, typical for atopic sensitization, another type of T(H)2 response exists. On chronic allergen exposure with the concomitant induction of germinal centers, IgG4-switched B memory cells are induced that are slow to differentiate into plasma cells. These IgG4-switched B memory cells might occasionally undergo a secondary switch to IgE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131584     DOI: 10.1016/j.jaci.2004.02.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

1.  The design and implementation of the immune epitope database and analysis resource.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen P Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-14       Impact factor: 2.846

Review 2.  Effects of protein aggregates: an immunologic perspective.

Authors:  Amy S Rosenberg
Journal:  AAPS J       Date:  2006-08-04       Impact factor: 4.009

Review 3.  Emerging antigens involved in allergic responses.

Authors:  Thomas A E Platts-Mills; Scott P Commins
Journal:  Curr Opin Immunol       Date:  2013-10-03       Impact factor: 7.486

4.  IgG4-related Inflammatory Abdominal Aortic Aneurysm, Spectrum of IgG4-related Chronic Periaortitis.

Authors:  Satomi Kasashima; Yoh Zen
Journal:  Ann Vasc Dis       Date:  2010-12-02

Review 5.  Drug allergens and food--the cetuximab and galactose-α-1,3-galactose story.

Authors:  Emily A Berg; Thomas A E Platts-Mills; Scott P Commins
Journal:  Ann Allergy Asthma Immunol       Date:  2013-12-21       Impact factor: 6.347

Review 6.  Delayed anaphylaxis to red meat masquerading as idiopathic anaphylaxis.

Authors:  Anubha Tripathi; Scott P Commins; Peter W Heymann; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol Pract       Date:  2014 May-Jun

Review 7.  Murine models of Omenn syndrome.

Authors:  Serre-Yu Wong; David B Roth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 8.  Therapeutic manipulation of immune tolerance in allergic disease.

Authors:  Mübeccel Akdis; Cezmi A Akdis
Journal:  Nat Rev Drug Discov       Date:  2009-08       Impact factor: 84.694

9.  Human B-cell isotype switching origins of IgE.

Authors:  Timothy J Looney; Ji-Yeun Lee; Krishna M Roskin; Ramona A Hoh; Jasmine King; Jacob Glanville; Yi Liu; Tho D Pham; Cornelia L Dekker; Mark M Davis; Scott D Boyd
Journal:  J Allergy Clin Immunol       Date:  2015-08-22       Impact factor: 10.793

10.  Changes in cat specific IgE and IgG antibodies with decreased cat exposure.

Authors:  Elizabeth A Erwin; Judith A Woodfolk; Hayley R James; Shama M Satinover; Thomas A E Platts-Mills
Journal:  Ann Allergy Asthma Immunol       Date:  2014-04-13       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.